FDA
-
-
-
-
-
-
-
FDA expands Anktiva approval to include papillary-only bladder cancer
-
-
-
-
-
-
-
ImmunityBio Appoints Dr. Jim Yong Kim, Former World Bank President and Global Health Leader, as Vice Chairman
-
-
-
-
-
-
-
ImmunityBio, Inc. Securities Fraud Class Action Result of FDA Warning and 21% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
-
-
-
-
-
-
ImmunityBio receives five US patents for cancer drug combination
-
-
-
-
-
-
-
ImmunityBio Addresses FDA Correspondence and Reaffirms Commitment to Advertising Compliance
-
-
-
-
-
-
-
FDA issues warning letter to ImmunityBio over misleading ANKTIVA ads
-
-
-
-
-
-
-
Immunitybio Inc (IBRX) PT Raised to $12 at Piper Sandler
-
335,228 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


